Srm Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.10 Cr
- Revenue Growth 21553.19%
- Profit Growth -337891.60%
- Net Worth -86.93%
- Total Assets 43.94%
About Srm Laboratories
Srm Laboratories Private Limited (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2015 (Nine years and nine months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.10 Cr.
Satyanarayana Bandaru and Prasad Devabhaktuni serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC098851
- Company No.
098851
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Srm Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Bandaru  | Director | 11-May-2015 | Current |
| Prasad Devabhaktuni | Director | 11-May-2015 | Current |
Financial Performance of Srm Laboratories.
Srm Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21553.19% increase. The company also saw a substantial fall in profitability, with a 337891.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 86.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Srm Laboratories?
In 2023, Srm Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amrutha Chemicals Pvt Ltd.Satyanarayana Bandaru and Prasad Devabhaktuni are mutual person
Charges (Loans)
₹8.10 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 7.50 Cr
- Indian Bank : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2022 | Indian Bank | ₹6.03 M | Open |
| 22 Jan 2018 | Others | ₹7.50 Cr | Open |
How Many Employees Work at Srm Laboratories?
Unlock and access historical data on people associated with Srm Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srm Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srm Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
